Drug details
Minivelle (estradiol transdermal system)
type of Estrogen Derivatives
Minivelle (estradiol transdermal system) is a form of the female hormone estrogen, used to treat moderate to severe vasomotor symptoms due to menopause.
This drug may have the following side effects:
- nausea,
- headache,
- vomiting,
- indigestion,
- runny or stuffy nose,
- constipation,
- joint pain,
- weight changes,
- depression,
- weight gain,
- insomnia,
- anxiety,
- back pain,
- flu symptoms,
- upper respiratory tract infection,
- bloating,
- changes in menstrual periods,
- skin redness or irritation at the application site,
- breast tenderness,
- neck pain,
- pain in the extremities,
- hot flashes, and
- high blood pressure.
The following drugs are related to Minivelle, either as a replacement or used together:
- Aromasin (exemestane)
- Atelvia (risedronate sodium delayed-release tablets)
- Boniva (ibandronate sodium)
- Boniva Injection (ibandronate sodium injection)
- Climara (estradiol transdermal)
- Climara Pro (estradiol, levonorgestrel transdermal)
- Estratest (esterified estrogens and methyltestosterone)
- EstroGel (estradiol gel)
- Evista (raloxifene)
- Femara (letrozole)
- Forteo (teriparatide (rdna origin) injection)